Cross-sectional Study to Characterize Real World Burden of Disease in Patients With Vitiligo in China

Status: Recruiting
Location: See all (2) locations...
Study Type: Observational
SUMMARY

The purpose of this study is to evaluate the patterns of treatment, healthcare resources utilized and the burdens associated with non-segmental vitiligo (NSV) amongst participants in China This study is a cross-sectional, multicenter, observational study of vitiligo patients in China. The cross-sectional design is sufficient to characterize the overall current burden of NSV.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 12
Maximum Age: 99
Healthy Volunteers: f
View:

• Male and female patients, age ≥ 12.

• Chinese patients meet the diagnosis of Non-Segmental Vitiligo (NSV) and 5≤ Total Vitiligo Area Scoring Index (T-VASI\<50) with or without facial involvement.

• Medical history available within the last 6 months.

• Ability to understand the questionnaires, with parental support as required for adolescents (between ≥ 12 and \< 18 years of age at inclusion visit).

• Willing to provide a patient authorization form to use and disclose personal health information (or informed consent, where applicable) to participate in the study; for adolescent subjects, authorization and/or consent will be provided by a parent or legal guardian, where applicable.

Locations
Other Locations
China
Shandong Dermatological Hospital /ID# 276918
RECRUITING
Jinan
Suzhou Municipal Hospital /ID# 276948
RECRUITING
Suzhou
Contact Information
Primary
AbbVie China Evidence Solutions
es_china@abbvie.com
021-62631436
Time Frame
Start Date: 2025-07-17
Estimated Completion Date: 2025-12
Participants
Target number of participants: 100
Related Therapeutic Areas
Sponsors
Leads: AbbVie

This content was sourced from clinicaltrials.gov